CleanCapital and Upstream Bio Lead the Week’s Top 10 Funding Rounds

CleanCapital and Upstream Bio Lead the Week’s Top 10 Funding Rounds

Clean energy and biotechnology companies have been leading the way in the latest round of funding, with CleanCapital and Upstream Bio taking the top spots in the week’s top 10 funding rounds.

CleanCapital, a New York-based clean energy investment platform, raised $300 million in a Series C funding round led by BlackRock Real Assets. The funding will be used to expand CleanCapital’s portfolio of solar and energy storage projects across the United States.

Upstream Bio, a California-based biotechnology company, raised $105 million in a Series B funding round led by Viking Global Investors. The company is developing a platform for the discovery and development of new medicines using synthetic biology.

Other notable funding rounds from the week include:

– Freenome, a California-based biotechnology company, raised $270 million in a Series C funding round led by Bain Capital Life Sciences. The company is developing a blood test for early cancer detection.

– Suki.AI, a California-based healthcare technology company, raised $20 million in a Series B funding round led by Flare Capital Partners. The company is developing an AI-powered digital assistant for doctors.

– Viz.ai, a California-based healthcare technology company, raised $71 million in a Series C funding round led by Scale Venture Partners. The company is developing an AI-powered platform for stroke care.

The latest round of funding highlights the growing interest in clean energy and biotechnology companies, as investors look for opportunities to support innovative solutions to some of the world’s most pressing challenges.

Clean energy companies are playing a critical role in the transition to a low-carbon economy, as governments and businesses around the world seek to reduce their carbon footprint and meet their climate targets. Meanwhile, biotechnology companies are developing new treatments and therapies for a range of diseases, from cancer to Alzheimer’s.

As these industries continue to grow and evolve, investors are likely to remain interested in supporting companies that are making a positive impact on the world. With the latest round of funding, CleanCapital and Upstream Bio are well-positioned to continue their work in these important areas.

• SEO Powered Content & PR Distribution. Get Amplified Today.
• EVM Finance. Unified Interface for Decentralized Finance. Access Here.
• Quantum Media Group. IR/PR Amplified. Access Here.
• PlatoAiStream. Web3 Data Intelligence. Knowledge Amplified. Access Here.
• Source: Plato Data Intelligence.